Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of LRRK2 in the regulation of dopamine receptor trafficking
Mauro Rassu, Maria Grazia Del Giudice, Simona Sanna, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0179082-e0179082
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches
Loredana Leggio, Silvia Vivarelli, Francesca L’Episcopo, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 12, pp. 2698-2698
Open Access | Times Cited: 198
Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease
Xiansi Zeng, Wen-Shuo Geng, Jing Jia, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 178
Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors
Shufen Liu, Tingting Liu, Jingwen Li, et al.
Neuroscience Bulletin (2025)
Closed Access | Times Cited: 2
Recent Advances in Biomarkers for Parkinson’s Disease
Runcheng He, Xinxiang Yan, Jifeng Guo, et al.
Frontiers in Aging Neuroscience (2018) Vol. 10
Open Access | Times Cited: 152
3D Cultures of Parkinson's Disease‐Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing
Silvia Bolognin, Marie Fossépré, Xiaobing Qing, et al.
Advanced Science (2018) Vol. 6, Iss. 1
Open Access | Times Cited: 126
Development of Small Molecules Targeting α-Synuclein Aggregation: A Promising Strategy to Treat Parkinson’s Disease
Samuel Peña‐Díaz, Javier García‐Pardo, Salvador Ventura
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 839-839
Open Access | Times Cited: 29
Golgi Fragmentation in Neurodegenerative Diseases: Is There a Common Cause?
José A. Martínez‐Menárguez, Mónica Tomás, Narcisa Martínez-Martínez, et al.
Cells (2019) Vol. 8, Iss. 7, pp. 748-748
Open Access | Times Cited: 73
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease
Yashumati Ratan, Aishwarya Rajput, Ashutosh Pareek, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 73-73
Open Access | Times Cited: 8
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Alessandro Tozzi, Michela Tantucci, Saverio Marchi, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 2
Open Access | Times Cited: 47
Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
Christian Ulrich von Linstow, Ziv Gan‐Or, Patrik Brundin
Translational Neurodegeneration (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Diabetes mellitus and Parkinson’s disease: dangerous liaisons between insulin and dopamine
Carlo Colosimo, Angela De Iuliis, Ennio Montinaro, et al.
Neural Regeneration Research (2021) Vol. 17, Iss. 3, pp. 523-523
Open Access | Times Cited: 30
Central nervous system interaction and crosstalk between nAChRs and other ionotropic and metabotropic neurotransmitter receptors
Federica Bono, Chiara Fiorentini, Veronica Mutti, et al.
Pharmacological Research (2023) Vol. 190, pp. 106711-106711
Open Access | Times Cited: 11
Neuronal Glutamate Transporters Control Dopaminergic Signaling and Compulsive Behaviors
Stefania Bellini, Kelsey E. Fleming, Modhurika De, et al.
Journal of Neuroscience (2017) Vol. 38, Iss. 4, pp. 937-961
Open Access | Times Cited: 36
Serum microRNA expression levels in Turkish patients with Parkinson’s disease
Betül Özdilek, Berna Demircan
International Journal of Neuroscience (2020) Vol. 131, Iss. 12, pp. 1181-1189
Closed Access | Times Cited: 32
Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations
Pilar Rivero‐Rios, María Romo-Lozano, Belén Fernández, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1719-1719
Open Access | Times Cited: 30
LRRK2 at the pre‐synaptic site: A 16‐years perspective
Francesca Pischedda, Giovanni Piccoli
Journal of Neurochemistry (2020) Vol. 157, Iss. 2, pp. 297-311
Open Access | Times Cited: 29
Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice
Daniela Mercatelli, Alberto Brugnoli, Anna Maio, et al.
Neurobiology of Disease (2025), pp. 106881-106881
Open Access
LRRK2 mediates haloperidol-induced changes in indirect pathway striatal projection neurons
Chuyu Chen, Meghan Masotti, Nathaniel Shepard, et al.
Molecular Psychiatry (2025)
Open Access
Cholesterol-activated stress granules reduce the membrane localization of DRD2 and promote prolactinoma dopamine agonists resistance
Yuyang Peng, Huachun Yin, Xiangdong Pei, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
The role of LRRK2 in cytoskeletal dynamics
Laura Civiero, Susanna Cogo, Alice Biosa, et al.
Biochemical Society Transactions (2018) Vol. 46, Iss. 6, pp. 1653-1663
Closed Access | Times Cited: 31
Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes
Alessandra Masala, Simona Sanna, Sonia Esposito, et al.
Neuroscience (2018) Vol. 390, pp. 1-11
Closed Access | Times Cited: 29
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease
Alessandro Tozzi, Valentina Durante, Guendalina Bastioli, et al.
Neurobiology of Disease (2018) Vol. 118, pp. 1-8
Open Access | Times Cited: 28
The Parkinson’s disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4
Natalja Funk, Marita Munz, Thomas Ott, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson’s Disease
Giulia Lamonaca, Mattia Volta
Cells (2020) Vol. 9, Iss. 5, pp. 1115-1115
Open Access | Times Cited: 24
In Parkinson's patient-derived dopamine neurons, the triplication of α-synuclein locus induces distinctive firing pattern by impeding D2 receptor autoinhibition
Min Lin, Phillip Mackie, Fatima Shaerzadeh, et al.
Acta Neuropathologica Communications (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top